Clinical Trial Update: Diabetic Under 70 (Diabetics Below 70)

View source ↗

Summary

AstraZeneca-sponsored clinical trial has completed, involving participants with diabetes and hyperlipidemia, with atherosclerosis also listed among conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Diabetes Mellitus
• Hyperlipidemia

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes, Hyperlipidemia | Status: COMPLETED